Phosphate disturbance in critically ill children: Incidence, associated risk factors and clinical outcomes

Ahmed Nabih El Shazly1, Doaa Refaey Soliman1, Effat Hussien Assar2

  • 1Department of Pediatrics, Faculty of Medicine, Benha University, Benha Qualubia, 13511, Egypt.

Insights

Hypophosphatemia is common in critically ill children, affecting 62% by day 7. This condition is linked to longer pediatric intensive care unit (PICU) stays but not increased mortality.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Endocrinology
  • Clinical Nutrition

Background:

  • Hypophosphatemia is a frequent complication in critically ill patients, often overlooked.
  • It can lead to serious complications and requires careful monitoring.

Purpose of the Study:

  • To determine the incidence of hypophosphatemia in critically ill children.
  • To investigate its association with clinical outcomes, including mortality and length of stay.
  • To identify potential risk factors for hypophosphatemia in this population.

Main Methods:

  • A study involving 50 pediatric intensive care unit (PICU) patients.
  • Serum phosphate levels measured on days 1 and 7 of PICU admission.
  • Analysis of risk factors including malnutrition, nutritional intake, and medication use (dopamine, furosemide, steroids, β2 agonists).

Main Results:

  • The incidence of hypophosphatemia was 42% on admission, rising to 62% by day 7.
  • Malnourished children had significantly lower serum phosphate levels (p=0.018).
  • Hypophosphatemia correlated with prolonged PICU stay (p<0.001) and mechanical ventilation, but not mortality (p=0.13).

Conclusions:

  • Hypophosphatemia is prevalent within the first week of PICU hospitalization.
  • It is associated with extended PICU stays and mechanical ventilation duration.
  • Medications like furosemide, dopamine, steroids, and β2 agonists are linked to hypophosphatemia.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
378
Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
17.0K